Your browser doesn't support javascript.
loading
Pentoxifylline for the prevention of contrast-induced nephropathy in diabetic patients undergoing angioplasty: a randomized controlled trial.
Aslanabadi, Naser; Afsar Gharebagh, Roghayeh; Moharramzadeh, Saba; Entezari-Maleki, Taher.
Affiliation
  • Aslanabadi N; Cardiovascular Research Center, Tabriz University of Medical Sciences, Daneshgah Street, Tabriz, Iran.
  • Afsar Gharebagh R; Cardiovascular Research Center, Tabriz University of Medical Sciences, Daneshgah Street, Tabriz, Iran.
  • Moharramzadeh S; Department of Clinical Pharmacy, Faculty of Pharmacy, Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Entezari-Maleki T; Cardiovascular Research Center, Tabriz University of Medical Sciences, Daneshgah Street, Tabriz, Iran. tentezari@gmail.com.
Int Urol Nephrol ; 51(4): 699-705, 2019 Apr.
Article in En | MEDLINE | ID: mdl-30830654

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pentoxifylline / Free Radical Scavengers / Contrast Media / Cystatin C / Acute Kidney Injury Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int Urol Nephrol Year: 2019 Document type: Article Affiliation country: Iran Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pentoxifylline / Free Radical Scavengers / Contrast Media / Cystatin C / Acute Kidney Injury Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Int Urol Nephrol Year: 2019 Document type: Article Affiliation country: Iran Country of publication: Netherlands